Luciana Borio

Q: What Schools Are Affiliated With Luciana Borio

Luciana Borio is affiliated with the following schools: George Washington University, Johns Hopkins University, University of Pittsburgh

Luciana Borio's AcademicInfluence.com Rankings

Luciana Borio

Medical

#1237

World Rank

#1556

Historical Rank

#362

USA Rank

Public Health

#275

World Rank

#284

Historical Rank

#67

USA Rank

medical Degrees

Luciana Borio

Philosophy

#10018

World Rank

#13690

Historical Rank

#1815

USA Rank

Logic

#7002

World Rank

#8602

Historical Rank

#998

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Luciana Borio Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council, acting chief scientist of the U.S. Food and Drug Administration , assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the public health responses to Ebola and Zika outbreaks.

(See a Problem?)

Luciana Borio's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hemorrhagic fever viruses as biological weapons: medical and public health management. (2002) (671)
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. (1999) (183)
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. (2001) (179)
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States (2020) (147)
Management of anthrax. (2002) (125)
Evaluating Ebola therapies--the case for RCTs. (2014) (74)
The WHO Declaration of Monkeypox as a Global Public Health Emergency. (2022) (73)
The use of oral washes to diagnose Pneumocystis carinii pneumonia: a blinded prospective study using a polymerase chain reaction-based detection system. (2001) (64)
Considerations for Developing a Zika Virus Vaccine. (2016) (59)
Hospital preparedness for pandemic influenza. (2006) (51)
Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis. (2020) (49)
The FDA animal efficacy rule and biodefense (2007) (46)
Smallpox vaccination in 2003: key information for clinicians. (2003) (44)
Death Due to Bioterrorism-Related Inhalational Anthrax (2001) (32)
Combating Emerging Threats--Accelerating the Availability of Medical Therapies. (2015) (26)
Navigating the storm: report and recommendations from the Atlantic Storm exercise. (2005) (25)
Inhalational anthrax: radiologic and pathologic findings in two cases. (2003) (24)
Healthcare epidemiology: the current status of planning for pandemic influenza and implications for health care planning in the United States. (2008) (20)
Scientists urge DHS to improve Bioterrorism Risk Assessment. (2008) (19)
Maintaining a Safe Blood Supply in an Era of Emerging Pathogens. (2016) (18)
Removing barriers to global pandemic influenza vaccination. (2006) (14)
Biomedical Advanced Research and Development Authority (BARDA) roundtable. (2007) (13)
Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasures. (2007) (12)
Anthrax countermeasures: current status and future needs. (2005) (11)
Pandemic diseases preparedness and response in the age of COVID‐19—a symposium report (2020) (11)
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics. (2022) (11)
A US Food and Drug Administration perspective on evaluating medical products for Ebola (2016) (10)
Meeting the challenges of medical countermeasure development (2012) (10)
Clinical Development Strategies and Considerations for Zika Vaccine Licensure (2017) (10)
Meeting Report Hospital Preparedness for Pandemic Influenza (2006) (8)
The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA. (2021) (6)
Right Job, Wrong Tool: A Commentary on Designing Clinical Trials for Ebola Virus Disease (2015) (4)
Chapter 58 – Smallpox and Monkeypox (2006) (3)
Response to Ezell and von Winterfeldt (2009) (3)
Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities. (2016) (3)
Facilitating Antibacterial Drug Development in a Time of Great Need. (2016) (3)
15 Bioterrorism An Overview (2014) (2)
Key information regarding smallpox vaccine. (2003) (1)
PLOS Medicine 2015 Reviewer Thank You (2016) (1)
Modes of Transmission of Hemorrhagic Fever (2017) (0)
Modes of Transmission of Hemorrhagic Fever (2017) (0)
Bioterrorism (2014) (0)
CLINICAL PATHOLOGICAL CONFERENCE (2002) (0)
Contributors (2008) (0)
Modes of Transmission of Hemorrhagic Fever—Reply (2002) (0)
Contributors (2015) (0)
The rapid spread of Zika virus through the Americas and its devastating consequences for pregnant women and infants have precip (2016) (0)
Plague as a Bioterrorism Weapon (2010) (0)

This paper list is powered by the following services:

Other Resources About Luciana Borio

en.wikipedia.org

What Schools Are Affiliated With Luciana Borio?

Luciana Borio is affiliated with the following schools:

Luciana Borio's Academic­Influence.com Rankings

Why Is Luciana Borio Influential?

Luciana Borio's Published Works

Published Works

Other Resources About Luciana Borio

What Schools Are Affiliated With Luciana Borio?

Image Attributions

Luciana Borio's AcademicInfluence.com Rankings